Approval · Notice of Compliance 14721 · 2013
PROLIA: Notice of Compliance 14721
Issued September 5, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14721
- Date
- September 5, 2013
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update
- Therapeutic class
- Human monoclonal antibody to rankl, bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROLIA | Not yet assigned | — |
Medicinal ingredients
- DENOSUMAB 60 MG per ML